Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 24;14(1):e21541.
doi: 10.7759/cureus.21541. eCollection 2022 Jan.

Symptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India

Kiran Kumar Prathipati  1 , Meena Mishra  2 , Bharatsing Rathod  3 , Jaya P Tripathy  4 , Shrikrishna B H  5 , Vijay Bidkar  5 , Sandeep Dabhekar  5 , Vishal Shete  2 , Deepa G  6
Affiliations

Symptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India

Kiran Kumar Prathipati et al. Cureus. .

Abstract

The COVID-19 pandemic has affected the world population across the globe. India has the second largest number of cases and the third largest number of deaths due to COVID-19 in the world. There have been close to 4.4 lakh deaths due to COVID-19 in India alone. The second wave in India has led to devastating consequences, particularly among the young population. The initial clinical symptoms of COVID-19 are similar to all types of viral pneumonia, with varying degrees of severity. The cases' clinical manifestations include fever, nonproductive cough, dyspnea, myalgia, and fatigue. This study was undertaken with the purpose of identifying the relationship between the symptoms and duration in COVID-19-affected patients. The common presenting symptoms were fever (44.5%), sore throat (38.7%), and cough (36.12%). Most of the cases presented with a combination of fever with cough (35%) and fever with sore throat (33%). The duration of symptoms varied from one to 17 days with a mean of 5.75 days. Despite vaccination being started, the risk of the imminent third wave in the country is existential. Mutations in the coronavirus pose a threat to the vulnerable population. It is important to identify the combination of symptoms most predictive of COVID-19 to help guide recommendations for self-isolation, testing, and preventing further spread of the disease. Further studies using these models can yield better results in surveillance and containing this infectious disease.

Keywords: coronavirus; covid-19; duration; pandemic; symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow diagram for the conduct of the study
Figure 2
Figure 2. Distribution of cases according to the ICMR categories
Cat 1: Symptomatic international traveler in last 14 days Cat 2: Symptomatic contact of a laboratory-confirmed case Cat 3: Symptomatic healthcare worker Cat 4: Severe acute respiratory illness (SARI) patient Cat 5a: Asymptomatic direct and high-risk contact of a laboratory-confirmed case Cat 5b: Asymptomatic healthcare worker in contact with a confirmed case without adequate protection Cat 6: Symptomatic influenza-like illness (ILI) patient in MoHFW-identified clusters Cat 8: Symptomatic influenza-like illness among returnees and migrants within seven days of illness Cat: category
Figure 3
Figure 3. Distribution of symptoms of the COVID-19 patients
*Others: ear discharge, generalized weakness, fatigue, rash, abdominal pain
Figure 4
Figure 4. Duration of symptoms of the COVID-19 patients
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
    DiIorio M, Kennedy K, Liew JW, Putman MS, Sirotich E, Sattui SE, Foster G, Harrison C, Larché MJ, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Massy M, Howard RA, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpízar-Rodríguez D, Beesley RP, Berenbaum F, Bulina I, Chock EY, Conway R, Duarte-García A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DF, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann JS, Simard JF, Sparks JA. DiIorio M, et al. RMD Open. 2022 Sep;8(2):e002587. doi: 10.1136/rmdopen-2022-002587. RMD Open. 2022. PMID: 36104117 Free PMC article.

References

    1. WHO Coronavirus (COVID-19) Dashboard. [ Sep; 2021 ];https://covid19.who.int/ 2021
    1. Implications of the second wave of COVID-19 in India. Asrani P, Eapen MS, Hassan MI, Sohal SS. Lancet Respir Med. 2021;9:0–4. - PMC - PubMed
    1. Coronavirus variants are spreading in India — what scientists know so far. [ Sep; 2021 ];https://www.nature.com/articles/d41586-021-01274-7 2021 - PubMed
    1. Why is India having a covid-19 surge? Thiagarajan K. https://doi.org/10.1136/bmj.n1124 BMJ. 2021;373:0. - PubMed
    1. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Wang D, Hu B, Hu C, et al. JAMA. 2020;323:1061–1069. - PMC - PubMed

LinkOut - more resources